Switch theme
Sign up to access all valuation multiples
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
2010
107
LTM Revenue $0.1M
LTM EBITDA -$76.5M
$43.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Fractyl Health has a last 12-month revenue of $0.1M and a last 12-month EBITDA of -$76.5M.
In the most recent fiscal year, Fractyl Health achieved revenue of $0.1M and an EBITDA of -$92.9M.
Fractyl Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Fractyl Health valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $0.1M | $0.1M | XXX | XXX | XXX |
| Gross Profit | n/a | $43K | XXX | XXX | XXX |
| Gross Margin | NaN% | 46% | XXX | XXX | XXX |
| EBITDA | -$50.5M | -$92.9M | XXX | XXX | XXX |
| EBITDA Margin | -42125% | -99843% | XXX | XXX | XXX |
| Net Profit | -$46.5M | -$77.1M | XXX | XXX | XXX |
| Net Margin | -38711% | -82894% | XXX | XXX | XXX |
| Net Debt | n/a | $21.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Fractyl Health's stock price is $1.
Fractyl Health has current market cap of $48.7M, and EV of $43.7M.
See Fractyl Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $43.7M | $48.7M | XXX | XXX | XXX | XXX | $-1.56 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Fractyl Health has market cap of $48.7M and EV of $43.7M.
Fractyl Health's trades at 659.6x LTM EV/Revenue multiple, and -0.6x LTM EBITDA.
Analysts estimate Fractyl Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Fractyl Health and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $43.7M | XXX | XXX | XXX |
| EV/Revenue | 469.9x | XXX | XXX | XXX |
| EV/EBITDA | -0.5x | XXX | XXX | XXX |
| P/E | -0.7x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -0.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpFractyl Health's NTM/LTM revenue growth is -100%
Fractyl Health's revenue per employee for the last fiscal year averaged $1K, while opex per employee averaged $0.9M for the same period.
Over next 12 months, Fractyl Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Fractyl Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Fractyl Health and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -22% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -99843% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 84% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $1K | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.9M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 75775% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 100617% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Fractyl Health acquired XXX companies to date.
Last acquisition by Fractyl Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Fractyl Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Fractyl Health founded? | Fractyl Health was founded in 2010. |
| Where is Fractyl Health headquartered? | Fractyl Health is headquartered in United States of America. |
| How many employees does Fractyl Health have? | As of today, Fractyl Health has 107 employees. |
| Who is the CEO of Fractyl Health? | Fractyl Health's CEO is Dr. Harith Rajagopalan, M.D.,PhD. |
| Is Fractyl Health publicy listed? | Yes, Fractyl Health is a public company listed on NAS. |
| What is the stock symbol of Fractyl Health? | Fractyl Health trades under GUTS ticker. |
| When did Fractyl Health go public? | Fractyl Health went public in 2024. |
| Who are competitors of Fractyl Health? | Similar companies to Fractyl Health include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Fractyl Health? | Fractyl Health's current market cap is $48.7M |
| What is the current revenue of Fractyl Health? | Fractyl Health's last 12-month revenue is $0.1M. |
| What is the current EBITDA of Fractyl Health? | Fractyl Health's last 12-month EBITDA is -$76.5M. |
| What is the current EV/Revenue multiple of Fractyl Health? | Current revenue multiple of Fractyl Health is 659.6x. |
| What is the current EV/EBITDA multiple of Fractyl Health? | Current EBITDA multiple of Fractyl Health is -0.6x. |
| What is the current revenue growth of Fractyl Health? | Fractyl Health revenue growth between 2023 and 2024 was -22%. |
| Is Fractyl Health profitable? | Yes, Fractyl Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
